Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v11-FR Version v8-EN
Language French English
Date Updated 2020-01-16 2019-10-01
Drug Identification Number 02439379 02439379
Brand name ROPIVACAINE HYDROCHLORIDE INJECTION, USP ROPIVACAINE HYDROCHLORIDE INJECTION, USP
Common or Proper name Ropivacaine Ropivacaine
Company Name FRESENIUS KABI CANADA LTD FRESENIUS KABI CANADA LTD
Ingredients ROPIVACAINE HYDROCHLORIDE ROPIVACAINE HYDROCHLORIDE
Strength(s) 2MG 2MG
Dosage form(s) SOLUTION SOLUTION
Route of administration EPIDURAL INFILTRATION EPIDURAL INFILTRATION
Packaging size 200mL Freeflex bag 200mL Freeflex bag
ATC code N01BB N01BB
ATC description ANESTHETICS, LOCAL ANESTHETICS, LOCAL
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-07-26 2019-07-26
Estimated end date 2019-10-31 2019-10-31
Actual end date 2020-01-03
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Available from January 3, 2020 100mL available for substitution
Health Canada comments